Info

DURECT Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s pharmaceutical systems enable optimized therapy for a given disease or patient population by controlling the rate and duration of drug administration, as well as for certain applications, placement of the drug at the intended site of action. DURECT Corporation’s drug delivery technology platforms include SABER Delivery System, ORADUR Delivery System, TRANSDUR Delivery System, DURIN Biodegradable Implant, DUROS System and MICRODUR. The Company’s development efforts are focused on the application of its pharmaceutical systems technologies to products in a variety of chronic and episodic disease areas, including pain, central nervous system (CNS) disorders, cardiovascular disease and other chronic diseases.(Source: 10-K)